ô¼ö¼º ±ÙÀ§ÃàÁõ ½ÃÀå : À¯Çüº°, Ä¡·á¹ýº°, ¿¬·ÉÃþº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, Áö¿ªº°
Spinal Muscular Atrophy Market, by Type, by Treatment, by Age Group, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
»óǰÄÚµå : 1705866
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,197,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,640,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,772,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ô¼ö¼º ±ÙÀ§ÃàÁõ ½ÃÀåÀº 2025³â 20¾ï 1,890¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 48¾ï 9,890¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 13.5%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 20¾ï 1,890¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020³âºÎÅÍ 2024³â±îÁö ¿¹Ãø ±â°£ 2025³âºÎÅÍ 2032³â±îÁö
¿¹Ãø ±â°£ : 2025-2032³â CAGR 13.50 2032³â °¡Ä¡ ¿¹Ãø 48¾ï 9,890¸¸ ´Þ·¯
±×¸². ô¼ö¼º ±ÙÀ§ÃàÁõ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2025³â
Spinal Muscular Atrophy Market-IMG1

ô¼ö¼º ±ÙÀ§ÃàÁõ(SMA)Àº ¸»ÃʽŰæ°è, ÁßÃ߽Űæ°è, ÀÇÁö±Ù ¿îµ¿(°ñ°Ý±Ù)¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â À¯Àüº´À¸·Î, ÁÖ·Î ½Å°æ¼¼Æ÷ÀÇ ÀÚ±ØÀ» ¹ÞÁö ¾Ê´Â ±ÙÀ°¿¡ ¿µÇâÀ» ¹ÌÄ¡±â ¶§¹®¿¡ ±ÙÀ°¼º ÁúȯÀÔ´Ï´Ù. À§ÃàÀº ÀÇÇпë¾î·Î ±ÙÀ°ÀÌ ¼öÃàÇÏ´Â °ÍÀ» ÀǹÌÇϸç, ½Å°æ¼¼Æ÷ÀÇ ÀÚ±ØÀ» ¹ÞÁö ¸øÇÏ´Â ±ÙÀ°ÀÌ À§ÃàµÇ´Â °ÍÀ» ¸»Çϸç, SMA´Â ¿îµ¿ ´º·± ÁúȯÀ¸·Î ô¼öÀÇ ¿îµ¿ ´º·±À̶ó´Â ½Å°æ¼¼Æ÷°¡ ¼Ò½ÇµÇ´Â ÁúȯÀÔ´Ï´Ù. SMA ȯÀÚ´Â »ýÁ¸¿îµ¿´º·±1(SMN1) À¯ÀüÀÚÀÇ ÀÌ»ó(µ¹¿¬º¯ÀÌ) ¶Ç´Â °á¼ÕÀ» 2°³¾¿ ¹°·Á¹Þ°Ô µÇ¸ç, ÁÖ·Î ¿µ¾Æ³ª ¼Ò¾Æ¿¡°Ô ¹ßº´ÇÏÁö¸¸ ¼ºÀο¡°Ôµµ ¹ßº´ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀÇ Á¦Ç° Ãâ½Ã°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 8¿ù, ÀϺ»¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â Á¦¾àȸ»ç Áß¿ÜÁ¦¾àÀº ô¼ö¼º ±ÙÀ§ÃàÁõ(SMA) Ä¡·áÁ¦·Î ¿¡ºê¸®½ºµð °ÇÁ¶½Ã·´ 60mg(ÀϹݸí: ¸®½ºµðÇ÷³)À» Ãâ½ÃÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

¶ÇÇÑ, ÁÖ¿ä ±â¾÷µéÀÇ Á¦ÈÞ ¹× °øµ¿ ¿¬±¸¿Í °°Àº ¹«±â Àü·«ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 3¿ù, ¼¼°è SMA ¿¬±¸ÀÇ ÁÖ¿ä ÀÚ±Ý Á¦°øÀÚÀΠô¼ö¼º ±ÙÀ§ÃàÁõ Àç´Ü°ú ¹Ì±¹ Á¦¾àȸ»ç PTC Therapeutics, Inc.´Â SMA ¹× ±âŸ ½Å°æ±ÙÀ° Áúȯ¿¡ ´ëÇÑ °úÇÐÀû ¿¬±¸¸¦ ´õ¿í ¹ßÀü½Ã۱â À§ÇØ »õ·Î¿î Ä¡·á¹ý ¹× Àç»ý ÀÇÇÐ °³¹ß¿¡ ÃÊÁ¡À» ¸ÂÃá »õ·Î¿î Á¦ÈÞ¸¦ ü°áÇß½À´Ï´Ù. ¸¦ ü°áÇß½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ Ã´¼ö¼º ±ÙÀ§ÃàÁõ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ô¼ö¼º ±ÙÀ§ÃàÁõ ¼¼°è ½ÃÀå, À¯Çüº°, 2020-2032³â

Á¦6Àå ¼¼°èÀÇ Ã´¼ö¼º ±ÙÀ§ÃàÁõ ½ÃÀå, Ä¡·áº°, 2020-2032³â

Á¦7Àå ¼¼°èÀÇ Ã´¼ö¼º ±ÙÀ§ÃàÁõ ½ÃÀå, ¿¬·Éº°, 2020-2032³â

Á¦8Àå ¼¼°èÀÇ Ã´¼ö¼º ±ÙÀ§ÃàÁõ ½ÃÀå, Åõ¿© °æ·Îº°, 2020-2032³â

Á¦9Àå ¼¼°èÀÇ Ã´¼ö¼º ±ÙÀ§ÃàÁõ ½ÃÀå, À¯Åë ä³Îº°, 2020-2032³â

Á¦10Àå ¼¼°èÀÇ Ã´¼ö¼º ±ÙÀ§ÃàÁõ ½ÃÀå, Áö¿ªº°, 2020-2032³â

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Ãßõ»çÇ×

Á¦13Àå ¼½¼Ç

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Spinal Muscular Atrophy Market is estimated to be valued at USD 2,018.9 Mn in 2025 and is expected to reach USD 4,898.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 13.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2,018.9 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 13.50% 2032 Value Projection: USD 4,898.9 Mn
Figure. Spinal Muscular Atrophy Market Share (%), By Region 2025
Spinal Muscular Atrophy Market - IMG1

Spinal muscular atrophy (SMA) is a genetic disease that affects the peripheral nervous system, central nervous system, and voluntary muscle movement (skeletal muscle). SMA is muscular since it primarily affects muscles, which do not receive impulses from the nerve cells. Atrophy is the medical term for shrinking, which is what muscles do when they are not stimulated by nerve cells. SMA is a motor neuron disease that includes the loss of nerve cells termed motor neurons in the spinal cord. It mostly affects infants and children but can also develop in adults. An individual with SMA inherits two copies of a faulty (mutated) or missing survival motor neuron 1 (SMN1) gene.

Market Dynamics

The increasing product launches by the key players in the market are expected to drive the market growth over the forecast period. For instance, in August 2021, Chugai Pharmaceutical Co., Ltd., a drug manufacturer operating in Japan, announced that it had launched Evrysdi Dry Syrup 60 mg (generic name: risdiplam) for the treatment of spinal muscular atrophy (SMA).

Moreover, the increasing adoption of inorganic strategies such as partnerships and collaborations by the key players is expected to drive the market growth over the forecast period. For instance, in March 2021, the Spinal Muscular Atrophy Foundation, the leading funder of SMA research worldwide, and PTC Therapeutics, Inc., a U.S. based pharmaceutical company, entered into a new collaboration focused on developing new treatments and regenerative medicine to further advance scientific research in SMA and other neuromuscular disorders.

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Spinal Muscular Atrophy Market- Impact of Coronavirus (Covid-19) Pandemic

5. Global Spinal Muscular Atrophy Market, By Type, 2020 - 2032, (US$ Million)

6. Global Spinal Muscular Atrophy Market, By Treatment, 2020 - 2032, (US$ Million)

7. Global Spinal Muscular Atrophy Market, By Age, 2020 - 2032, (US$ Million)

8. Global Spinal Muscular Atrophy Market, By Route of Administration, 2020 - 2032, (US$ Million)

9. Global Spinal Muscular Atrophy Market, By Distribution Channel, 2020 - 2032, (US$ Million)

10. Global Spinal Muscular Atrophy Market, By Region, 2020 - 2032, (US$ Million)

11. Competitive Landscape

12. Analyst Recommendation

13. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â